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Abstract
Background: Physiological stress evokes rapid changes in both the innate and adaptive immune response. Immature ab T
cells developing in the thymus are particularly sensitive to stress, with infections and/or exposure to lipopolysaccharide or
glucocorticoids eliciting a rapid apoptotic program. MicroRNAs are a class of small, non-coding RNAs that regulate global
gene expression by targeting diverse mRNAs for degradation. We hypothesized that a subset of thymically encoded
microRNAs would be stress responsive and modulate thymopoiesis. We performed microRNA profiling of thymic microRNAs
isolated from control or stressed thymic tissue obtained from mice. We identified 18 microRNAs that are dysregulated .1.5-
fold in response to lipopolysaccharide or the synthetic corticosteroid dexamethasone. These included the miR-17-90 cluster,
which have anti-apoptotic functions, and the miR-181 family, which contribute to T cell tolerance. The stress-induced
changes in the thymic microRNAs are dynamically and distinctly regulated in the CD4
2CD8
2, CD4
+CD8
+, CD4
+CD8
2, and
CD4
2CD8
+ thymocyte subsets. Several of the differentially regulated murine thymic miRs are also stress responsive in the
heart, kidney, liver, brain, and/or spleen. The most dramatic thymic microRNA down modulated is miR-181d, exhibiting a 15-
fold reduction following stress. This miR has both similar and distinct gene targets as miR-181a, another member of miR-181
family. Many of the differentially regulated microRNAs have known functions in thymopoiesis, indicating that their
dysregulation will alter T cell repertoire selection and the formation of naı ¨ve T cells. This data has implications for clinical
treatments involving anti-inflammatory steroids, ablation therapies, and provides mechanistic insights into the
consequences of infections.
Citation: Belkaya S, Silge RL, Hoover AR, Medeiros JJ, Eitson JL, et al. (2011) Dynamic Modulation of Thymic MicroRNAs in Response to Stress. PLoS ONE 6(11):
e27580. doi:10.1371/journal.pone.0027580
Editor: George Kassiotis, MRC National Institute for Medical Research, United Kingdom
Received July 21, 2011; Accepted October 19, 2011; Published November 16, 2011
Copyright:  2011 Belkaya et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by grants from the National Institutes of Health AI42953 and AI31839 (NvO), and the Jeffery Modell Foundation
(MdlM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nicolai.vanoers@utsouthwestern.edu
. These authors contributed equally to this work.
Introduction
The thymus is the critical organ required for the production of
the ab T lymphocytes of the immune system, a developmental
process maintained throughout life [1,2,3]. Selection mechanisms
within the thymus ensures the development of naı ¨ve T cells
capable of recognizing foreign peptides bound to self-major
histocompatibility complex (MHC) molecules, which are presented
in the peripheral lymphoid organs [1]. These self-restricted T cells
are essential for effective immune responses to infections.
Interestingly, developing thymocytes are exquisitely sensitive to
physiological and pathological stress, which causes a rapid
programmed cell death termed apoptosis [4,5]. This response is
evident during infections, as well as in humans undergoing
immunosuppressive treatments, radiation therapy, and/or surgery
[6,7,8,9]. Even milder stress such as pregnancy, emotional anxiety,
malnutrition, or alcoholism can reduce thymic cellularity
[10,11,12,13]. All these forms of stress increase the systemic
and/or intrathymic production of glucocorticoids, which are
major regulators of lymphocyte apoptosis [14,15]. In the case of
bacterial infections, the innate immune system responds to
pathogen associated molecular patterns (PAMPs), releasing
inflammatory cytokines, such as interferon, IL-1b, TNF-a, IL-6,
and leukemia inhibitory factor (Lif) [11,16,17]. The IL-6 family
(oncostatin-M, IL-6, leukemia inhibitory factor) induces the
production of corticosteroids (glucocorticoids (GC)) from the
hypothalamus, pituitary-adrenal (HPA) axis and intrathymically
[18,19,20]. Influenza virus also elevates glucocorticoids systemi-
cally, albeit via undefined mechanisms [21]. Clinically, synthetic
glucocorticoids (e.g. dexamethasone, methylprednisone) are rou-
tinely used to suppress immune functions in transplant recipients,
during autoimmune and systemic inflammatory disorders, and for
treating certain malignancies [22,23,24]. The effects of these
treatments on thymopoiesis are becoming better understood with
the identification of down-regulated genes that are coupled to T
cell development, cell cycle, and cell activation [25]. Functionally,
GCs, lipophilic steroids, diffuse across the plasma membrane and
complex a specific member of the nuclear receptor family,
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glucocorticoid-bound receptor complex dimerizes and translocates
into the nucleus where it interacts with glucocorticoid response
elements (GREs), culminating in the trans-activation of apoptotic
effector genes [4,14,26,27]. Thymocytes are very sensitive to
glucocorticoid-induced cell death because of high levels of NR3C1
[4,28].
MicroRNAs (miRs) are key, stress-responsive regulators in the
immune, hematopoietic, cardiac, thyroid, and auditory systems
[29,30,31,32,33]. They are small, non-coding RNA molecules
(20–25 nucleotides in length) that repress global mRNA translation
and/or induce mRNA degradation (reviewed in [33,34]). Within
hours of exposure to GCs, the protein levels of three miR-
processing enzymes, Drosha, Pasha/DiGeorge Critical Region 8
(DGCR8), and Dicer are reduced significantly in thymocytes [35].
These enzymes/miR-binding proteins generate small miRs from
the larger pre-miRs processed from various RNA transcripts. The
targeted deletion of Dicer and Drosha in developing thymocytes
causes a significant loss of cells, and results in a lethal lymphoid
inflammatory disorder, partly from the loss of T regulatory cells
[36,37,38]. Thus, a transient loss of Dicer and Drosha following
GC treatment could modulate T cell development. There are
several additional miRs with key roles in thymopoiesis. MiR-181a
is highly expressed in DP thymocytes, representing 15% of the
total miR pool [39,40,41]. This particular miR targets genes that
regulate T cell receptor signaling pathways [40,41]. The normally
high levels of miR-181a maintain T cell tolerance to self-peptide/
MHC molecules, with a reduction in this miR increasing the
number of self-reactive T cells [42]. Less is known about the role of
the three other miR-181 family members (miR-181b, c, and d),
two of which are expressed in developing thymocytes [39]. The
targeted deletion of miR-146a in T regulatory cells results in
rampant autoimmunity [43]. While little is known about the effects
of stress on the thymic miRs, certain miRs are up regulated in
innate effector cells following bacterial infections and/or LPS
exposure (MiR-146a, MiR-155) [29,43,44,45,46,47]. Given the
critical function of T cells in the immune system, the modulation
of miRs during thymopoiesis could have important clinical
consequences.
Herein, we describe 18 thymic miRs that are dysregulated .1.5
fold in mice exposed to LPS or dexamethasone for one to three
days. Many of these miRs exhibited a distinct responsiveness in
immature versus mature thymocyte subsets, with the CD4
2CD8
+
subset the most refractory to miR down-regulation. MiR-181d, a
member of the miR-181 family, had a 5–15 fold reduced
expression following LPS or dexamethasone treatment, suggesting
an important functional role for this miR in thymopoiesis. By
performing luciferase reporter assays with defined targets, miR-
181d targeted a similar set of genes as miR-181a. In addition,
miR-181d uniquely targeted Lif. These experiments indicate that
stress can have a profound impact on thymopoiesis, altering the
expression of miRs involved in apoptosis, tolerance, and
proliferation.
Results
LPS and synthetic steroids reduce CD4
+CD8
+ thymocyte
numbers
Stress, resulting from infections, induces thymocyte apoptosis
and suppresses peripheral T cell responses [16,17,18,19,27]. A
single intraperitoneal (IP) injection of 100 mg lipopolysaccharide
(LPS), used to mimic a bacterial infection, caused a significant
reduction in the percentage of CD4
+CD8
+ (DP) thymocytes within
24 h (Figure 1A). These DP cells were almost completely
eliminated by 72 h (Figure 1A). The reduced percentage of DP
cells results from LPS-induced elevations in glucocorticoids [19].
Consistent with this, an IP injection of 60 mg dexamethasone
(Dex), a synthetic glucocorticoid, also caused a significant loss of
the DP thymocytes that was revealed within 24 h (Figure 1A).
While both treatments increased the percentage of CD4
+CD8
2
and CD4
2CD8
+ (SP) thymocytes, the absolute numbers of these
SP cells were not altered (Figures 1A–C). This indicated that the
DP subset was selectively targeted (Figures 1B–C). Unlike
thymocytes, the consequences of LPS and Dex injections on
peripheral lymphocytes were distinct. LPS increased the number
of mature B cells (B220
+) at 48 h while Dex caused a depletion of
both B and T cells at specific time points (Figure S1A–D). Taken
together, these results indicate that DP thymocytes are acutely
sensitive to stress induced by both LPS and Dex.
Selected thymic microRNAs are differentially regulated in
diverse tissues following stress
Three miR processing enzymes, Drosha, Pasha/DGCR8, and
Dicer, are significantly reduced in thymocytes within 6–12 h of
glucocorticoid treatment, leading to an overall reduction in the
miRs in the thymus [35]. Our findings suggested that the most
dramatic changes in thymocyte subset composition occurred at
72 h. To profile the miRs at this time point, RNA was prepared
from the thymus of mice 72 h after treatment with PBS or LPS.
Murine microRNA arrays were used to profile over 600 miRs
(Data Set S1). Seven and 11 distinct miRs were up- and down-
regulated, respectively, at levels greater than 1.5-fold (p,0.05, 3
mice/group, 6 mice total) (Figure 2A, Figure S1E). The changes in
14 of the 18 miRs were confirmed by northern blotting using
probes specific for each miR, with U6 RNA as an internal control
for RNA levels. MiR-125b-5p, miR-150, miR-205, and miR-342-
3p were consistently up regulated in the thymic tissue from the
LPS injected mice (Figure 2B). MiR-15a, miR-17, mir-20a, miR-
20b, miR-106a, miR-128, miR-181a, miR-181b, and miR-181d
were consistently down regulated (Figure 2C). While miR-26b
appeared down regulated, based on the microRNA array data,
northern blots did not consistently reveal this change (Figure 2C).
MiR-1224, miR-709, and miR-705 could not be characterized by
northern blotting due to high, non-specific background issues with
the probes (data not shown). MiR-185 gave a weak signal when
assessed by northern blotting (data not shown). Of note, the fold
changes revealed in the miR microarrays were much greater than
that identified by northern blotting because the arrays are more
sensitive, specific, and quantitative [48].
We next examined whether any of the miRs identified in the
thymus were stress responsive in other tissues [39]. Northern
blotting was performed using RNA isolated from the heart, kidney,
liver, brain, spleen, and thymus of PBS-, LPS- and Dex-treated
mice at 72 h post-injection (Figure 2D, Figure S2B). While miR-
150 was identified in both the spleen and thymus, it only appeared
up regulated in the thymic tissue following LPS or Dex treatments
(Figure 2D). MiR-205 and miR-181d were uniquely expressed and
stress responsive in the thymic tissue. MiR-128, identified in the
brain and thymus, was only down regulated in the latter following
a stress response. Of the miR-181 family members that were stress
responsive in the thymus, miR-181a and miR-181b were also
weakly expressed in the brain and spleen. Many of the other miRs
were stress responsive in diverse tissues. For example, miR-15a,
miR-17, miR-20b, and miR-26b were stress responsive in nearly
every tissue examined (Figure S2C). MiR-342-3p, primarily brain-
and spleen- specific, was reduced upon LPS and Dex treatment.
MiR-20b, miR-106a and miR-150 were stress responsive, but
were only identified in the thymus and spleen. MiR-125b-5p was
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levels in other tissues. Taken together, our experiments reveal that
many of the miRs identified in the thymus are stress responsive in
different tissues.
The miR array profiling was undertaken at a single time point
(72 h). To determine the temporal alterations in miR levels
following LPS or Dex treatments, northern blots were performed
with RNA extracted from the thymus at 24, 48, and 72 h. MiR-
125b-5p and miR-150 exhibited a transient, 2-fold increase 24 h
post-LPS and -Dex injections (Figure 3A, lanes 2 and 5 versus 1).
MiR-150 continued to increase and plateaued between 48 and
72 h (Figure 3A, lanes 6–7). Unlike miR-150, miR-125b-5p was
primarily expressed in stromal tissue, as it was not detected in
purified thymocytes (lanes 8–9). This is consistent with our
microarray data comparing differential miR expression in the
thymus between wild type and CD3e
2/2 mice (Figure S2A). MiR-
181a transiently increased in the LPS-treated mice at 24 h, but
thereafter dropped 1- and 5-fold upon LPS and Dex treatments,
respectively (Figure 3C, lanes 4–7). MiR-181d exhibited the most
dramatic down-regulation after both LPS and Dex treatments;
with a 5–15 fold reduction by 72 h (Figure 3D, lanes 3, 5–7). The
other miRs exhibited time dependent changes in expression
(Figure S3). In summary, at least 18 distinct miRs expressed in the
thymus are dynamically regulated following LPS and Dex induced
stress responses.
MicroRNA expression patterns are differentially affected
by stress in specific thymocyte subsets
To determine whether the stress-responsive miRs were
equivalently or differentially regulated in particular T cell subsets,
thymocytes from control and LPS-injected mice were sorted into
the DN, DP, CD4 SP, and CD8 SP subsets. MiR profiling was
performed using quantitative real-time PCR (RT-PCR) with miR-
specific probes (Figure 4A–D). With the exception of miR-150 and
miR-342-3p, the majority of the miRs were down regulated in the
DN subset. The reduced expression of the miR-17-90 cluster and
the miR-181 family was even more pronounced in the DP
population (Figure 4B). Comparing all the thymocyte subsets, the
CD8 SP was the most divergent, with the miR-17-90 cluster up
regulated 2-fold and the miR-181 group unaffected by the LPS
treatment. It should be noted that the down-regulation of the miR-
181 family was not as obvious with the RT-PCR assays as with the
arrays. This is because miR-181a, miR-181b, miR-181c, and
miR-181d are very conserved, with only 1–4 bp differences within
this family. Since the PCR amplification is not as stringent as the
arrays, and it is likely that miR-181a can be amplified to a small
degree when using a miR-181d specific primers, causing a less
obvious down-regulation. In summary, LPS exposure induces a
dynamic, time-dependent modulation of miRs that is distinct in
each of the thymocyte subsets.
Mir-181a and miR-181d have both overlapping and
distinct gene targets
The stress-responsive thymic miRs identified in our profiling
were grouped into subsets based on their collective functions and/
or sequence similarity. Many genes, linked to specific cellular
programs such as stress responses or cell cycle, are down regulated
in the thymus following LPS exposure [25]. We used public miR
target prediction databases, such as TargetScan [49], Miranda
[50], PicTar [51], and RNAhybrid [52], to identify potential
stress-responsive genes targeted by the miRs identified (Table 1).
The miR-181 family members have overlapping targets such as
Cd69, Prox1, Bcl-2, dual specificity phosphatases, and protein
tyrosine phosphatases (Table 1). MiR-181a is required for effective
T cell tolerance to self-antigens. However, little is known about its
family member, miR-181d. While all murine miR-181 family
members have the same seed region (nucleotides 2–8 at the 59
end), miR-181d is the most divergent based on total pre-miR
sequence, and its precise function is unknown (Figure 5A) [53,54].
MiR-181d was the most dramatically down-regulated miR in our
profiling study. Leukemia inhibitory factor (Lif) is a key, stress-
responsive gene identified in the thymus [18,19]. It is a member of
the IL-6 cytokine family, expressed by thymic epithelial cells and T
lymphocytes, which elevates GC levels following LPS exposure
[18,19,55]. Interestingly, the 39 untranslated region (UTR) of Lif
contains 5 putative miR-181 binding sites (Figure S4A). To
determine whether miR-181a and miR-181d have overlapping or
distinct target specificities, the 39 UTRs of murine Cd69, Prox1,
and Lif were cloned downstream of a luciferase reporter construct
(Figure 5B). Cd69 and Prox-1 are previously reported miR-181a
targets [41,54], and are used in this study as positive controls for
miR-181a. Luciferase reporter assays were performed in the
absence or presence of miR-181a or miR-181d, using beta-
galactosidase to normalize the transfection efficiency. We found
that luciferase activities of both Cd69 and Prox1 were repressed in
cells expressing miR-181a or miR-181d, compared to the vector
controls (Figure 5C). These findings were consistent with a dose
response analysis (Figure S5). However, the over-expression of
miR-181d, but not miR-181a, reduced the luciferase activity when
Lif was located at the 39end of the reporter (Figure 5C). This was
confirmed by using a mutant version of Lif, which demonstrated
no targeting by miR-181d (Fig. 5C). These experiments indicate
that miR-181 family members can have both overlapping and
distinct gene targets.
Discussion
MiRs have critical roles in the development, differentiation, and
expansion of cells in many organ systems. Stress directly affects the
biogenesis and functionality of miRs (reviewed in [56]). We
describe a set of miRs expressed in the thymus that are
differentially regulated following the introduction of systemic
stress in vivo. The stress was induced by LPS to mimic bacterial
infections, and by Dex, the known modulator of LPS-induced
thymocyte apoptosis. Many of the miRs present in the thymus that
were down regulated following LPS or Dex injection belong to the
miR-17-92 cluster, which are anti-apoptotic [57]. The miR-17-92
cluster includes miR-17, miR-20a, miR-20b, and miR-106a. Their
down-regulation is consistent with the increased apoptotic
program initiated in the thymocytes. Previous work has shown
that this same cluster is significantly down regulated in thymocytes
Figure 1. Lipopolysaccharide and dexamethasone deplete immature CD4
+CD8
+ thymocytes. A) Thymocytes were isolated from either
control (PBS injected, t=72 h), or LPS and dexamethasone (Dex) injected mice (t=24, 48 and 72 h). The cells were stained with fluorochrome-labeled
anti-CD4 and anti-CD8 mAbs and analyzed by flow cytometry. The percentage of CD4
2CD8
2 (DN), CD4
+CD8
+ (DP), CD4
+CD8
2 (CD4 SP), and
CD4
2CD8
+ (CD8 SP) subsets are provided in each quadrant of the dot plot profiles. B) The total thymic cellularity and the number of CD4
+CD8
+ cells
were calculated at 24, 48, and 72 h post-injection and are shown in a log scale. C) The absolute number of mature CD4
+CD8
2 and CD4
2CD8
+ SP cells
after PBS, LPS, and Dex treatments were calculated at t=24, 48 and 72 h post-injection. Data are representative of mean +/2 SD from at least 8 mice
per group (*p,0.05, **p,0.01, *** p,0.001, versus PBS control; one-way ANOVA analyses).
doi:10.1371/journal.pone.0027580.g001
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Dex treatments cause a reduction in most miRs due to diminished
levels of three key MiR processing enzymes, Dicer, Drosha, and
Pasha/DGCR8 [35]. Consequently, no thymic miRs are increased
in expression. We examined the longer-term consequences of
stress on thymic miRs. As the thymocyte subpopulations are
dramatically altered following stress, we also examined the miRs
changes in individual thymocyte subsets. For the DP population,
the miR-17-92 cluster is reduced at all time points examined. This
reduction is unique to the DP subset since the cluster is unchanged
in the CD4 SP cells, and up regulated in the CD8 SP population.
The loss of this cluster in the DP subset is consistent with the
increased programmed cell death evident in these cells. We
hypothesize that such a change is necessary to prevent tolerogenic
Figure 2. Stress responsive signature microRNAs in thymic tissue. A) Graph shows 18 distinct miRs with a statistically significant fold change
(p,0.05) in expression. Fold change indicates the change in miR expression in LPS-treated sample relative to PBS-treated sample. B) Northern blots of
4 miRs that were up regulated in thymic tissue 72 h after LPS injections. C) Northern blots were performed on 10 miRs that were down-regulated
72 h after LPS exposure. D) Differential expression of stress responsive miRs in diverse tissues. Male mice were injected with PBS, LPS or Dex. Total
RNA was isolated from the brain, spleen, and thymus of control (PBS) and LPS- or Dex- treated mice at 72 h post-injection. The individual miRs (miR-
150, miR-205, miR-128, miR-181a, miR-181b, miR-181d) were detected by Northern blotting. The relative amounts of a control RNA were determined
by blotting for U6.
doi:10.1371/journal.pone.0027580.g002
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present. Furthermore, we speculate that the up-regulation of the
miR-17-92 cluster in the CD8 SP cells may be important in
preventing these cells from dying during infections, providing for a
new source of naı ¨ve T cells required for maintaining an ongoing
immune response. It is interesting to note that even among DP
thymocytes, several miRs are up regulated after 24 h of stress.
MiR-709, miR-1224, and miR-342-3p/5p are increased several-
Figure 3. Stress responsive changes in thymic miR profiles are time dependent. Total RNA was isolated from thymic tissue prepared from
PBS- (lane 1), LPS- (lanes 2–4), and Dex- (lanes 5–7) treated mice at 24 h (lanes 2, 5), 48 h (lanes 3, 6), and 72 h (lanes 1, 4, 7). In lanes 8–9, RNA was
prepared from purified T cells isolated from the thymus. Northern blots were performed for the selected miRs A) Mir-125, B) MiR-150, C) MiR-181a,
and D) MiR-181d. The samples were quantified by phoshorimager analyses, following background subtraction, and normalizing for total RNA
amounts with a U6 probe. Data shown are mean +/2 SD of relative fold changes in miR expression levels of PBS- versus LPS- or Dex-treated samples
from 3 to 5 independent Northern blots (*p,0.05, **p,0.01, *** p,0.001, versus PBS control; unpaired Student t-test).
doi:10.1371/journal.pone.0027580.g003
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increased in all the thymocyte subsets. Contrasting these findings,
miR-150 is up regulated 2–3.5 fold in the mature SP subsets, while
remaining unchanged in the DP population. It is noteworthy that
elevations of miR-150 in the hematopoietic system, via retroviral
transduction, cause early developmental arrest of B cells and
contribute to myeloid leukemia’s [58]. This suggests that long-term
stress could promote a developmental arrest of the DN cells via the
up-regulation of miR-150, the target of which is c-Myb [59]. A
number of stress responsive miRs have been characterized in
innate effector cells following LPS exposure or infections,
including miR-146, and miR-155 [29,47]. Interestingly, these
miRs are not modulated significantly in the thymocyte subsets,
implying that stress has distinct effects on the innate versus
adaptive immune system. It was noted that the magnitude of miR
modulation was not as accurate when using real-time RT-PCR
assays compared to the microRNA arrays. This is consistent with
the known RT-PCR disadvantages for quantitating miRs [48].
Of the stress responsive miRs identified in the thymus, miR-
181d is the most dramatically down-modulated miR. This miR is
a member of the miR-181 family, with all four members sharing
an almost identical seed sequence. MiR-181d is the most
divergent of the four, and is located approximately 100 bp
downstream of miR-181c. While both miR-181c and miR-181d
are expected to arise from the same polycistronic message, miR-
181c is not highly expressed in thymocytes, suggesting additional
post-transcriptional processes [39]. In addition, miR-181d and
miR-181c are encoded on a chromosome (murine chromosome
8) distinct from the miR-181a and miR-181b cluster, which have
undergone gene duplication on two separate chromosomes
(murine chromosomes 1 and 2). This difference could also
explain why miR-181d expression levels are very susceptible to
stress compared to miR-181a or miR-181b. The entire family has
a complex regulation and function. Thus, the pre-miR loop
nucleotides of miR-181a versus miR-181c result in the differential
ability of miR-181a to regulate thymocyte development com-
pared to miR-181c [53]. The stem-loop structure of miR-181d is
the most distinct of all members. These findings suggest
important functional distinctions between miR-181a and miR-
181d. MiR-181d is more highly expressed in induced T
Figure 4. Stress responsive thymic miRs are differentially regulated in thymocyte subsets. Thymocytes from PBS and LPS injected mice
(72 h) were sorted into A) CD4
2CD8
2 (DN), B) CD4
+CD8
+ (DP), C) CD4
+CD8
2 (CD4 SP), and D) CD4
2CD8
+ (CD8 SP) subsets using high speed cell
sorting. RNA was isolated from the sorted subpopulations. Real-time microRNA RT-PCR was used to detect the levels of the indicated miRs in various
subsets. The vertical line on the figure indicates the control (PBS) threshold set at 1. Data represent the averaged fold changes in miR expression
levels of PBS- versus LPS-treated samples calculated by DDCT normalized to the endogenous U6 levels, of 4 independent experiments performed in
triplicate (*p,0.05, **p,0.01, *** p,0.001, versus the threshold; one sample Student t-test).
doi:10.1371/journal.pone.0027580.g004
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family members [39]. Our luciferase reporter assays support
distinct functions for this family as Cd69 and Prox1 are targeted
by both miR-181a and miR-181d, while miR-181d preferentially
targets Lif. This finding is intriguing since the down regulation of
miR-181d would increase Lif levels in the thymus. LIF, OSM,
and IL-6 induce GC production in LPS-treated mice [18,19].
Thus, the entire miR-181 family could modulate stress responses
by targeting Lif and IL-6, especially since IL-6 is a putative target
of these miRs (Table 1). The differentially regulated miRs
expressed in the thymus may have functions systemically,
especially since miRs are very stable and are detected in the
plasma and tissue fluids, indicating that miRs are not restricted to
their site of production [60]. From a physiological perspective, we
suggest that stress-responsive miRs have crucial roles in the
specific elimination of DP thymocytes following stress, thereby
preventing tolerance to preventing tolerance to foreign, patho-
gen-derived antigens.
Materials and Methods
Ethics Statement
Procedures involving mice were carried out in accordance with
the Institutional Animal Care and Use Committee at the
University of Texas Southwestern Medical Center. All animal
use adheres to applicable requirements such as the Animal
Welfare Act, the Guide for the Care and Use of Laboratory
Animals, and the US Government Principals regarding the care
and use of animals. All protocols involving mice were approved
under the animal proposal number 2010-0053 (05/06/2010). The
mice were housed in the specific pathogen free facility on the
North campus of UT Southwestern Medical Center.
Mice
All mice used were on a C57BL/6 background. CD3 epsilon
deficient (CD3e
2/2) mice were provided by Dr. Paul Love of the
NIH [61]. The mice were housed in a Specific Pathogen Free
facility on the North Campus of the University of Texas
Southwestern Medical Center (Dallas, TX). Lipopolysaccharide
(LPS) and dexamethasone (Dex) were purchased from Sigma
Chemical Co (St. Louis, MO) and prepared at 1 mg/ml and
0.06 mg/ml (active component, 1.5610
24 M stock) in water,
respectively. Unless otherwise indicated, male mice of 5–8 weeks
of age were used in all the experiments involving injections with
PBS, LPS, or Dex.
Luciferase Reporter Assays
PCR-amplified genetic fragments (500–700 base pairs) contain-
ing miR-181a or miR-181d were cloned into the pCDNA3.1
vector (Invitrogen, Carlsbad, CA). The 39 untranslated regions of
murine Cd69, Prox1, and Lif genes were amplified by PCR and
ligated into the firefly luciferase reporter construct (pMIR-
REPORT, Ambion, Austin, TX). Primers sequences are provided
in Figure S4. These constructs were co-transfected in COS-7 cells
in combination with a beta-galactosidase expression vector, using
the Fugene 6 Transfection Reagent according to the manufactur-
er’s instructions (Roche, Indianapolis, IN). The total amount of
DNA per well was kept equivalent by adding the corresponding
amount of empty vector (pCDNA3.1). Forty-eight hours after
transfection, cells were harvested and analyzed for luciferase
expression using the Luciferase Assay Kit (Promega, Madison,
WI). Relative luciferase activity determined by the ratio of the
firefly luciferase normalized to the beta-galactosidase expression
levels for each of the transfectants. All transfections were
Table 1. List of putative and experimentally validated targets of stress-responsive thymic miRs.
Putative Targets
miR Fold Cell Division Response to Stress Validated Targets
miR-125b-5p 1.97 Nuf2 Smo, Map2k, Tnf
miR-150 2.38 Nek6 Cxcl1 c-Myb, Notch4
miR-205 3.36 Birc5, Cdc27 Boris, Pten
miR-342-3p 2.51 Ccnf, Cdc27, Kif11 Cfb, Cxcl9 Cadm1, Ccnd1, Wnt3a
miR-705 4.41 Ccnf Ccl5, Cxcl9 Rbl2, Mapk14, Stat3
miR-709 2.14 Cdc27, Cdc7, Mcm5 Stat3, Zbtb7a, Mapk14
miR-1224 3.17 Birc5, Cdc27, Cdc2a
miR-15a 24.66 Cdc27, Cdca7, Mcm5, Ncapg2 Ccl5, Cxcl10, Cxcl9, Rsad2, Bcl-2, Wnt3a, Ccnd1
miR-17 28.31 Smc2 Cfb, F3, Orm1 Bim, Pten, Mapk14, Stat3
miR-20a 23.42 Ccne2, Cdca7, Hells, Mcm5, Smc2, Nek6 Esco2, F3, Orm1, Serpina3n, Lif Aml1, Mapk14, Zbtb7a
miR-20b 26.43 Ccne2, Cdca7, Hells, Mcm5, Smc2, Nek6 F3, Orm1, Serpina3n, Lif Hipk3, Mylip, Hif1a
miR-26b 22.21 Birc5, Ccne2, Cdc7, Hells, Kntc1, Nek6, Smc2, Zbtb16 Ccl3, Cfb, Il-6, Lif Lef1
miR-106a 25.4 Cdc2a, Mcm5, Smc2, Nek6 Ccl2, F3, Orm1, Rsad2, Stat3, Hipk3, Mylip, Mapk14
miR-128 21.95 Nek6 Ccl2, Cxcl13, Il-6, Rsad2 Bmi1, Adora2b, E2f3, Tgfbr1
miR-181a 21.43 Aurkb, Ccnf, Cdc7, Kntc1, Smc2 Il-6, Lif Cd69, Tcra, Bcl2, Hoxa11, Ptpn22
miR-181b 25.64 Aurkb, Ccnf, Cdc7, Kntc1, Smc2 Il-6, Lif Aicda, Timp3, Bcl2
miR-181d 216.04 Aurkb, Ccnf, Cdc7, Kntc1, Smc2 Il-6, Lif Nlk, Bcl2
miR-185 21.95 Cdc27, Mcm5, Ncapg2, Zbtb16 Cxcl10, Cxcl5, Serpina3n, Thbs1, Lif Cdc42, RhoA, Dnmt1, Cdk6
The experimentally validated targets (from miRTarBase) were compiled for each miR. Putative target genes down- and up-regulated in the top two pathways upon
endotoxin-induced thymic atrophy are shown in normal and bold text, respectively.
doi:10.1371/journal.pone.0027580.t001
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least 3 separate occasions.
Cell Isolation and Analyses
Lymphocytes were isolated from the thymus and spleen as
previously described [62]. FACS
TM staining buffer consisted of
1% fetal calf serum in PBS containing Ca
2+ and Mg
2+ (Mediatech,
Herndon, VA). Between 1–2.5610
6 cells were pre-treated for 10–
30 minutes at 4uC with the 2.4G2 mAb to block non-specific Fc
receptor binding. Cells were then stained with the various
antibodies for 30 minutes at 4uC followed by washing and
analyses on flow cytometers. Ten thousand to 1610
6 cells per
sample were acquired on a FACSCalibur (BD Biosciences, San
Jose, CA). Data was analyzed using FlowJo software (Tree Star,
Inc., Ashland, OR). For isolating thymocyte subsets, 10
8
thymocytes from control- (PBS) and LPS-treated mice were
stained with anti-CD4-PE and anti-CD8-FITC labeled mAbs,
followed by high-speed cell sorting on a Mo-Flo (Cytomation).
One hundred thousand CD4
2CD8
2 (DN), CD4
+CD8
+ (DP),
CD4
+CD8
2 (CD4 SP), and CD4
2CD8
+ (CD8 SP) thymocytes
were sorted to .95% purity, lysed in 1.0 ml of Trizol, and
processed for total RNA as described below. In certain
experiments, single cell suspensions were prepared using thymo-
cytes from the control and LPS-treated mice. T cells were enriched
to greater than 95% purity from these cell suspensions with the
EasySep T cell Enrichment kits following the manufacturers’
guidelines (StemCell Technologies, Vancouver, Canada). The
brain, heart, and kidney were isolated using standard protocols,
and a small extract was used to isolate RNA. This was performed
in Trizol followed by Dounce homogenization.
RNA Analysis
Total RNA (including microRNA) was isolated from purified T
cells, thymocyte subsets, or tissue samples obtained from control
Figure 5. Target specificity of miR-181 family members. A) Homology of miR-181 family members with the seed sequences shaded.
B) Schematic representation of the reporter constructs and predicted binding sites of miR-181 family in the 39 untranslated region of Cd69, prox1, and
Lif. C–D) Luciferase reporter assays. A beta-galactosidase expressing vector, and luciferase reporter constructs containing the 39 untranslated region
of the murine Cd69, Prox1, and Lif (WT or with point mutations in two putative miR-181 binding sites (Mut. Lif) genes were co-transfected along with
vector alone or vectors expressing mir-181a or miR-181d. Firefly luciferase activity was normalized to beta-galactosidase activity. Each graph
represents mean +/2 SD of the ratio of the normalized luciferase activity in miR-181 and control vector transfections from three independent
experiments, with each sample tested in triplicate (n.s.=not significant, *p,0.05, **p,0.01, *** p,0.001, versus vector alone, unpaired Student
t-test).
doi:10.1371/journal.pone.0027580.g005
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procedures or the miRNeasy kit (Qiagen Inc., Valencia, CA),
based on the manufacturer’s instructions, respectively. RNA
quality was confirmed with an absorbance ratio at UV260/280
greater than 1.80. For northern blotting procedures, 5 mg of total
RNA was resolved on 15% urea/polyacrylamide gels and
transferred to Zeta probe membranes. Similar amounts of RNA
were loaded onto the gels, as assessed by ethidium bromide
staining prior to electrophoretic transfer to the membrane.
Following UV-cross linking, the membranes were probed with
selected miR probes labeled with [
32P]-dATP. The miR probes
contained a poly-A tail for radiolabeling under conditions
suggested by the manufacturer (Starfire kit, Idt DNA Technolo-
gies, Coralville, Iowa). Blots were exposed and quantified by using
a phosphorimager and ImageQuant (Bio-Rad Laboratories,
Hercules, CA). Detection of U6 levels were used an endogenous
controls to normalize total RNA input. For analysis of miR
expression levels in thymocyte subsets by real-time microRNA
PCR, total RNA was isolated using miRNeasy and DNase-
digested (Turbo-DNAse, Ambion). cDNA was made from 10 ng of
total RNA using the TaqMan MicroRNA Reverse Transcription
Kit (Applied Biosystems, Carlsbad, CA). Real-time PCR analysis
was performed using TaqMan Gene Expression Master Mix and
microRNA-specific TaqMan probes in the microRNA assays on
an ABI 7300 series PCR machine (Applied Biosystems) according
to the manufacturers’ recommendations. U6 small RNA (Applied
Biosystems) was used as an endogenous control for all miRs. All
reactions were performed in triplicate, and repeated at least three
times. Relative expression of miRs was calculated by the
comparative threshold method (DDCT). Student t-tailed tests were
performed using comparisons with a defined relative threshold set
at 1.
MicroRNA arrays
MicroRNA arrays were from LC Sciences (LS Sciences,
Houston, TX). In brief, 6 RNA samples (5 mg of total thymic
RNA per sample) were prepared from 3 control (PBS) and 3 LPS-
treated C57Bl/6 male mice of 6–8 weeks of age. These were sent
to LC Sciences for microRNA profiling. The RNA was labeled
with Cy3 (2 control mice and 1 LPS-injected mouse) or Cy5 (2
LPS injected mice and 1 control mouse). The various labeled
samples were analyzed on the microarray platform with a probe
set containing 649 murine miRs, based on the Sanger Version
12.0 and 13.0 database release (Data Set S1).
Statistical analyses
In the LPS and Dex treatments, one-way ANOVA was used to
determine the significance. For all other assays, unpaired Student’s
t-test was used for determining the significance. All data with
significant differences were indicated by one asterisk (p,0.05), two
asterisks (p,0.01), or three asterisks (p,0.001).
Supporting Information
Figure S1 Lipopolysaccharide and dexamethasone have
differential effects on peripheral lymphocytes. A) Lym-
phocytes were isolated from control (PBS injected, t=72 h), LPS,
or Dex injected mice (t=24, 48 and 72 h). The total lymphoid
cellularity was determined. B–D) The splenic cells were stained
with fluorochrome-labeled anti-B220, anti-CD3, anti-CD4, and
anti-CD8 mAbs and analyzed by flow cytometry. The absolute
number of B) B220
+ B cells, C) CD4
+CD8
2 T cells, and D)
CD4
2CD8
+ T cells were calculated at 24, 48, and 72 h post-
injection, after appropriate electronic gating to determine the
percentage of each population. Data are representative of mean
+/2 SD from at least 5 mice per group (*p,0.05, **p,0.01,
*** p,0.001 versus PBS control; one-way ANOVA analyses.
E) Representative heat map shows differential expression of
miRNAs in the thymus of control (PBS) and LPS-treated mice
(t=72 h). The samples were labeled with Cy3 and Cy5,
respectively, and used to probe a murine microRNA array
containing 649 miRs (LC Sciences). Red indicates high miR
expression; green indicates low miR expression in thymic tissue.
Data are shown for one of three separate microarray analyses with
control and LPS injected mice.
(TIF)
Figure S2 MiR expression patterns in different tissues.
A) Differential expression of microRNAs in the thymic tissue.
RNA was prepared from the thymus of age- and sex- matched
control and CD3e
2/2 C57BL/6 mice. The samples were used to
probe a murine microRNA array containing 649 miRs (LC
Sciences). Data represent differential expression levels of selected
miRs from two independent sample preparations. B) Differential
expression of stress responsive miRs in diverse tissues. Male mice
were injected with PBS, LPS or Dex. Total RNA was isolated from
the heart, kidney, and liver of control (PBS) and LPS- or Dex-
treated mice at 72 h post-injection. The individual miRs (miR-
150, miR-205, miR-128, miR-181a, miR-181b, miR-181d) were
detected by Northern blotting. The relative amounts of a control
RNA were determined by blotting for U6. C) Male mice were
injected with PBS, LPS or Dex. Total RNA was isolated from the
heart, kidney, liver, brain, spleen, and thymus of control (PBS) and
LPS- or Dex- treated mice at 72 h post-injection. The individual
miRs (miR-15a, miR-17, miR-20a, miR-20b, miR-26b, miR-
106a, miR-125-5p, miR-342-3p) were detected by Northern
blotting. The relative amounts of a control RNA were determined
by blotting for U6.
(TIF)
Figure S3 Stress responsive changes in thymic miR
profiles are time dependent. A) Total RNA was isolated from
thymic tissue prepared from PBS- (lane 1), LPS- (lanes 2–4), and
Dex-treated (5–7) mice at 24 h (lanes 2, 5), 48 h (lanes 3, 6), and
72 h (lanes 1, 4, 7). In lanes 8–9, T cell were purified from the
thymus preparation prior to Northern blotting for the selected
miRs. The samples were quantified by phoshoimager analyses,
following background subtraction, and controlling for total RNA
amounts with a U6 probe. Data shown is mean +/1 SD of relative
fold changes in miR expression levels of PBS- versus LPS- or Dex-
treated samples from 3–5 independent northern blots.
(TIF)
Figure S4 MiR-181 interaction sites within murine LIF.
A) Predicted interactions of miR-181a and miR-181d with their
binding sites in the murine LIF 39UTR. RNAhybrid algorithm
and the microRNA resource (www.microrna.org) were used to
assess potential miR binding target sites. B) List of primers used for
PCR amplification of miR-181a, miR-181d, and the Lif 39 UTR.
C) Mutation of the Lif sequences at site 1 and site 572 are shown.
The seed sequence of miR-181 is underlined.
(TIF)
Figure S5 Dose-response analysis of miR-181 target
genes. A beta-galactosidase expressing vector and the luciferase
reporter constructs containing the 39untranslated region of murine
Cd69, Prox1, and Lif genes were co-transfected along with vector
alone or vectors expressing miR-181a or miR-181d at the
indicated amounts (100 or 300 ng). Firefly luciferase was
normalized to beta-galactosidase activity. Each graph represents
Thymus MicroRNA Modulation during Stress
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in miR-181 and control vector transfections. This was done in
three independent experiments, with each sample tested in
triplicate or quadruplicate (n.s., not significant, * p,0.05,
** p,0.01, *** p,0.001 versus vector control, unpaired Student’s
t-test).
(TIF)
Data Set S1 Standard Data Analysis Report.
(PDF)
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